Basel, March 20, 2026 – Novartis today announced that it has entered into an agreement with Synnovation Therapeutics, LLC to acquire SNV4818, a pan-mutant‑selective PI3Kα inhibitor, exploring a ...
Novartis seeks to collaborate with Healthcare Professionals and Healthcare Organizations in interest of patients. As an industry we make payments or ‘transfers of value’ to Healthcare Professionals ...
Explore opportunities with Novartis below.
All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...
Shareholders approve all other proposals by the Board of Directors, including the reduction of share capital, the 2025 report on nonfinancial matters and the 2025 Compensation Report, as well as the ...
Auditoría y Finanzas BD&L & Strategic Planning Communications & Public Affairs Data and Digital Gerencia Comercial y General Instalaciones y Administración Interns/Students on Novartis Payroll Market ...
이 웹사이트에서 제공되는 제품 정보는 국내 허가 정보입니다.
Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives. Novartis works closely with healthcare professionals around the work to support ...
Novartis Pipeline Benefiting from our continued focus on innovation, Novartis has one of the industry’s most competitive pipelines. Many of these projects, which include new molecular entities as well ...
Annual Report 2025 and US Securities & Exchange Commission Form 20-F 2025 These reports provide a comprehensive overview of Novartis, including our company structure, corporate governance, operating ...
Albania Algeria Angola Argentina Armenia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Benin Bermuda Bolivia Bosnia and Herzegovina Brazil Bulgaria Burkina Faso ...
노바티스의 성과 지향 문화와 책임 있는 비즈니스 방식은 연구개발, 마케팅 및 영업, 재무 및 운영 등 다양한 분야의 최고 전문가들을 영입할 수 있는 핵심 요소입니다. 노바티스를 헬스케어 분야의 글로벌 선두주자로 이끈 것은 바로 우리의 인재들입니다. 노바티스는 자신의 아이디어와 시간을 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results